Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-05-01
|
| Series: | Asian Journal of Surgery |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958422015597 |
| _version_ | 1797836754742411264 |
|---|---|
| author | Ke Lian Qiao-Hua Zhang Shu-Ling Hou Li Li |
| author_facet | Ke Lian Qiao-Hua Zhang Shu-Ling Hou Li Li |
| author_sort | Ke Lian |
| collection | DOAJ |
| first_indexed | 2024-04-09T15:15:07Z |
| format | Article |
| id | doaj.art-777ccd70065c46ec8ec42efa3be51ed7 |
| institution | Directory Open Access Journal |
| issn | 1015-9584 |
| language | English |
| last_indexed | 2024-04-09T15:15:07Z |
| publishDate | 2023-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asian Journal of Surgery |
| spelling | doaj.art-777ccd70065c46ec8ec42efa3be51ed72023-04-30T06:05:36ZengElsevierAsian Journal of Surgery1015-95842023-05-0146520422044Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphomaKe Lian0Qiao-Hua Zhang1Shu-Ling Hou2Li Li3Department of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, ChinaCorresponding author. Department of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, No.99 of Longcheng Street, Xiaodian District, Taiyuan 030032, China.; Department of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, ChinaDepartment of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, ChinaDepartment of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, Chinahttp://www.sciencedirect.com/science/article/pii/S1015958422015597Non-Hodgkin's lymphomaB-cell lymphomaRelapseRefractoryMetronomic chemotherapyAntiangiogenesis therapy |
| spellingShingle | Ke Lian Qiao-Hua Zhang Shu-Ling Hou Li Li Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma Asian Journal of Surgery Non-Hodgkin's lymphoma B-cell lymphoma Relapse Refractory Metronomic chemotherapy Antiangiogenesis therapy |
| title | Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma |
| title_full | Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma |
| title_fullStr | Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma |
| title_full_unstemmed | Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma |
| title_short | Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma |
| title_sort | study of a metronomic chemotherapy regimen comprising prednisone etoposide and procarbazine combined with thalidomide rituxan for relapsed refractory b cell lymphoma |
| topic | Non-Hodgkin's lymphoma B-cell lymphoma Relapse Refractory Metronomic chemotherapy Antiangiogenesis therapy |
| url | http://www.sciencedirect.com/science/article/pii/S1015958422015597 |
| work_keys_str_mv | AT kelian studyofametronomicchemotherapyregimencomprisingprednisoneetoposideandprocarbazinecombinedwiththalidomiderituxanforrelapsedrefractorybcelllymphoma AT qiaohuazhang studyofametronomicchemotherapyregimencomprisingprednisoneetoposideandprocarbazinecombinedwiththalidomiderituxanforrelapsedrefractorybcelllymphoma AT shulinghou studyofametronomicchemotherapyregimencomprisingprednisoneetoposideandprocarbazinecombinedwiththalidomiderituxanforrelapsedrefractorybcelllymphoma AT lili studyofametronomicchemotherapyregimencomprisingprednisoneetoposideandprocarbazinecombinedwiththalidomiderituxanforrelapsedrefractorybcelllymphoma |